Evidence map›Paper›PMID 34047639›Full record

ArticleClinical toxicology (Philadelphia, Pa.)2022

Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen.

Brandon J Sonn, Kennon J Heard, Susan M Heard, Angelo D'Alessandro, Kate M Reynolds, Richard C Dart, Barry H Rumack, Andrew A Monte

Open access · greenAbstract read
In one paragraph

Article in Clinical toxicology (Philadelphia, Pa.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. A Multi-Omic Mosaic Model of Acetaminophen Induced Alanine Aminotransferase Elevation.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2023
    Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brandon J SonnDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0002-0105-2473
Kennon J HeardDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Susan M HeardRocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
Angelo D'AlessandroSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
Kate M ReynoldsRocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
Richard C DartRocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
Barry H RumackDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Andrew A MonteDepartment of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Denver Health Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
PERSONALIZING EMERGENCY/ACUTE THERAPEUTICS UTILIZING SYSTEMS BIOLOGY (PEGASUS)R35GM124939 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI MONTE, ANDREW ALBERT · 2017 to 2021
$2.1M
NCATS NIH HHS TL1 TR002533NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NIGMS NIH HHS R35 GM124939
6 · The paper itself

Abstract

backgroundDrug induced liver injury (DILI) remains a prominent global issue and acetaminophen (APAP) overdose represents a common cause of hepatic injury and DILI. Transient alanine aminotransferase (ALT) elevations have been documented while adhering to recommended daily dosing. However, no metabolites have been identified in pre-treatment samples predicting which patients will develop these transient increases.

methodsThis was a secondary analysis of samples collected from a parent study describing the course of ALT levels in subjects receiving therapeutic APAP dosing. Two hundred and four subjects recruited from Denver, Colorado received 4 g APAP/daily for at least 16 days. Subjects were grouped by ALT at any monitored time point above 60 units/L (

resultsWithin pre-treatment day 0 samples, allantoate and ornithine were significantly elevated in subjects of the ALT elevation group (

conclusionsAllantoate and ornithine are directly involved in pathways related to nitrogen release and urea production. Further investigation into alterations in the glutathione metabolism and urea cycle pathways may lead to a greater understanding of the mechanisms associated with hepatic adaptation for a variety of pharmaceuticals.

Indexed as

AcetaminophenChemical and Drug Induced Liver InjuryAlanine TransaminaseBiomarkersDrug OverdoseHumansLiverAcetaminophenAlanine TransaminaseBiomarkersalanine transaminaseDILIglutathione metabolismornithineUrea cycle

Identifiers

PMID34047639
PMCPMC8627525
OpenAlexW3165402833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.